Nerf_SSI: Quantification of Nerve Stiffness in Neuropathies

Sponsor
Nantes University Hospital (Other)
Overall Status
Unknown status
CT.gov ID
NCT03397303
Collaborator
Université de Nantes (Other)
100
1
2
24
4.2

Study Details

Study Description

Brief Summary

This project aims to understand how nerve mechanical properties are altered in patients with rare peripheral neuropathies . Stiffness of various peripheral nerves will be measured using ultrasound shear wave elastography. Patients will be compared with age-matched controls.

Condition or Disease Intervention/Treatment Phase
  • Other: elastography measurements
N/A

Detailed Description

The following nerve will be studied bilaterally, in a randomised order: Median, ulnar, Radial, Sciatic and Tibial.

Participants will be asked to remain relaxed during elastography measurements.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
100 participants
Allocation:
Non-Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Basic Science
Official Title:
Quantification of Nerve Stiffness in Patients With Peripheral Neuropathies
Anticipated Study Start Date :
Apr 1, 2018
Anticipated Primary Completion Date :
Apr 1, 2020
Anticipated Study Completion Date :
Apr 1, 2020

Arms and Interventions

Arm Intervention/Treatment
Experimental: patients with peripheral neuropathies

This project aims to understand how nerve mechanical properties are altered in patients with rare peripheral neuropathies . Stiffness of various peripheral nerves will be measured using ultrasound shear wave elastography. Patients will be compared with age-matched controls.

Other: elastography measurements
elastography measurements

Other: controls

Other: elastography measurements
elastography measurements

Outcome Measures

Primary Outcome Measures

  1. nerve shear wave velocity [Day0]

    Ultrasound shear wave elastography will provide a measure of nerve shear wave velocity, which will be used as a surrogate of nerve stiffness.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 65 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Male or female aged 18 to 65

  • Having social insurance status

  • Having given informed consent

  • Diagnostic of chronic inflammatory demyelinating polyradiculoneuropathy (CIDP), CMT1a or Anti-MAG (peak immunoglobulin M (IGm)>15,000 BTU)

Exclusion Criteria:
For controls:
  • Person staying in a health or social facility

  • Person unable to understand the protocol and to respect the modalities

  • Person deprived of liberty

  • Person of legal age benefiting from a system of legal protection (guardianship, curators or safeguard of justice)

  • Participation in another biomedical research in progress

  • Diabetes, history of neuromuscular disease

For CIDP:
  • Person staying in a health or social facility

  • Person unable to understand the protocol and to respect the modalities

  • Person deprived of liberty

  • Person of legal age benefiting from a system of legal protection (guardianship, curators or safeguard of justice)

  • Participation in another biomedical research in progress

  • MRC score < 3

For Charcot-Marie-Tooth type 1 (CMT1) and anti-MAG:
  • Person staying in a health or social facility

  • Person unable to understand the protocol and to respect the modalities

  • Person deprived of liberty

  • Person of legal age benefiting from a system of legal protection (guardianship, curators or safeguard of justice)

  • Participation in another biomedical research in progress

Contacts and Locations

Locations

Site City State Country Postal Code
1 Univeristy of Nantes Nantes France 44093

Sponsors and Collaborators

  • Nantes University Hospital
  • Université de Nantes

Investigators

  • Principal Investigator: Yann Pereon, PU-PH, Nantes University Hospital

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Nantes University Hospital
ClinicalTrials.gov Identifier:
NCT03397303
Other Study ID Numbers:
  • RC17_0231
First Posted:
Jan 11, 2018
Last Update Posted:
Mar 2, 2018
Last Verified:
Mar 1, 2018
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Mar 2, 2018